| Literature DB >> 29464466 |
Peter A Hunt1, Matthew D Segall2, Jonathan D Tyzack3.
Abstract
In the development of novel pharmaceuticals, the knowledge of how many, and which, Cytochrome P450 isoforms are involved in the phase I metabolism of a compound is important. Potential problems can arise if a compound is metabolised predominantly by a single isoform in terms of drug-drug interactions or genetic polymorphisms that would lead to variations in exposure in the general population. Combined with models of regioselectivities of metabolism by each isoform, such a model would also aid in the prediction of the metabolites likely to be formed by P450-mediated metabolism. We describe the generation of a multi-class random forest model to predict which, out of a list of the seven leading Cytochrome P450 isoforms, would be the major metabolising isoforms for a novel compound. The model has a 76% success rate with a top-1 criterion and an 88% success rate for a top-2 criterion and shows significant enrichment over randomised models.Entities:
Keywords: Cytochrome P450; Drug–drug interactions; Metabolism; Multi-class classification; Random forests
Mesh:
Substances:
Year: 2018 PMID: 29464466 DOI: 10.1007/s10822-018-0107-0
Source DB: PubMed Journal: J Comput Aided Mol Des ISSN: 0920-654X Impact factor: 3.686